- Data updates for Bomedemstat Phase 2 trials in Essential Thrombocythemia (ET) and Myelofibrosis (MF) to be presented at the American Society of Hematology (ASH) Annual Meeting in December 2022- - ...
100% (29/29) of patients experienced platelet count reduction to within normal ranges (150 – 400 x 109/L). 90% (26/29) of patients achieved a platelet count of less than 400 x 109/L without ...
Gays are created in the image of God. So are liberals. The rich. The undocumented. Unbelievers. Everyone, even, and most importantly, the people with whom you do not agree. That’s the message of the ...
Currently, I am only accepting new couples for therapy. I am open to working with all couples: gay, lesbian, straight, alternative lifestyles. I work with couples that are dating, living together, ...
Merck is introducing its tender offer to buy Imago BioSciences, the company announced Monday. Under the tender offer, which has not yet commenced, Merck would buy all of Imago’s outstanding shares of ...
The IMAGO Working Conditions Committee recently shared the results of its latest Behind the Lens study with the EU parliament, with the hope that it will help raise awareness of the poor working ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results